Kent C. B. Stalker

Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA.

Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA.

Vesteck, Inc. is an early-stage medical device company that focuses on bringing their proprietary technology to the aortic repair and structural heart markets. The company is based in West Chester, PA. The company's first product, the "suture-tight"™ nitinol suture delivery catheter, comes preloaded with 4 pairs of nitinol sutures, securing evar grafts to the aorta on initial implant or during repair procedures. The company was founded in 2019 by John Edoga, Thierry Richard. The CEO is Joseph W. Rafferty.

Vesteck, Inc. is an early-stage medical device company that focuses on bringing their proprietary technology to the aortic repair and structural heart markets. The company is based in West Chester, PA. The company's first product, the "suture-tight"™ nitinol suture delivery catheter, comes preloaded with 4 pairs of nitinol sutures, securing evar grafts to the aorta on initial implant or during repair procedures. The company was founded in 2019 by John Edoga, Thierry Richard. The CEO is Joseph W. Rafferty.

Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA.